Indo-Bangla Pharmaceuticals (DHA:IBP) Change In Inventory : BDT0.00 Mil (TTM As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals Change In Inventory?

Indo-Bangla Pharmaceuticals's change in inventory for the quarter that ended in . 20 was BDT0.00 Mil. It means Indo-Bangla Pharmaceuticals's inventory stayed the same from . 20 to . 20 .

Indo-Bangla Pharmaceuticals's change in inventory for the fiscal year that ended in . 20 was BDT0.00 Mil. It means Indo-Bangla Pharmaceuticals's inventory stayed the same from . 20 to . 20 .

Indo-Bangla Pharmaceuticals's Total Inventories for the quarter that ended in . 20 was BDT0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Indo-Bangla Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals Change In Inventory Chart

Indo-Bangla Pharmaceuticals Annual Data

Trend

Change In Inventory

Indo-Bangla Pharmaceuticals Semi-Annual Data

Change In Inventory

Indo-Bangla Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals (DHA:IBP) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Indo-Bangla Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/		*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Indo-Bangla Pharmaceuticals's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=		/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Indo-Bangla Pharmaceuticals's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/
	=	N/A

Indo-Bangla Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229

Website

http://www.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.